Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
BSX
HOLDBoston Scientific Corporation · Healthcare · United States · $65.8B · Avg Vol: $847M/d
COMPANY DESCRIPTION
Boston Scientific Corporation is a global developer, manufacturer, and marketer of interventional medical devices across specialties including cardiology, peripheral interventions, urology, and gastrointestinal health. The company maintains a strong competitive position through its robust R&D pipeline, extensive patent portfolio, and deep-rooted relationships with healthcare systems, which drive high switching costs for its advanced solutions. As a significant player in the medical technology sector, it consistently introduces innovative, life-changing devices.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.7B | 14.2B | 16.7B | 20.1B | 16.5% | 20.6B | 21.6B | 23.3B | 7.8% |
| EPS | 0.45 | 1.08 | 1.26 | 1.96 | 63.3% | 2.38 | 2.15 | 2.38 | 10.1% |
| Shares | 1.4B | 1.5B | 1.5B | 1.5B | +3.5% | 1.5B | — | — | — |
| Debt | 9.3B | 9.5B | 10.7B | 11.4B | 7.2% | 11.0B | — | — | — |
| Equity | 17.6B | 19.3B | 21.8B | 24.2B | 11.3% | — | — | — | — |
| Op CF | 1.5B | 2.5B | 3.4B | 4.5B | 43.8% | 4.3B | — | — | — |
| Inv CF | -2.0B | -2.6B | -5.7B | -2.6B | — | — | — | — | — |
| Fin CF | -548.0M | 5.0M | 1.8B | -395.0M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of BSX are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| BSX | Boston Scientific Corporation(you) | $65.8B | 60 | HOLD |
| SHL.DE | Siemens Healthineers AG | $43.6B | 57 | HOLD |
| EW | Edwards Lifesciences Corporation | $47.6B | 72 | BUY |
| SYK | Stryker Corporation | $126.6B | 66 | BUY |
| GEHC | GE HealthCare Technologies Inc. | $27.6B | 58 | HOLD |
| ABT.MX | Abbott Laboratories | $163.4B | 63 | HOLD |
| 2M6.DE | Medtronic plc | $104.4B | 75 | BUY |
| 300760.SZ | Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | $23.9B | 64 | HOLD |
| PEN | Penumbra, Inc. | $12.5B | 54 | HOLD |
| DXCM | DexCom, Inc. | $27.6B | 82 | STRONG BUY |
Peer medians: ROE 2.1% · P/E 23.4x · Gross margin 50.1%